Waleed H. Hassanein - 20 Feb 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: President & CEO, Director
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 20 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 22 Feb 2023, 19:00:21 UTC
Previous filing: 16 Feb 2023
Next filing: 27 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Award	$0	+37,332	+9.6%	$0.000000	426,444	20 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Award	$0	+57,165		$0.000000	57,165	20 Feb 2023	Common Stock	57,165	$66.10	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2	The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service.